NEDD9, an independent good prognostic factor in intermediaterisk acute myeloid leukemia patients
Supplementary
Survival, RR or CIR at 5 years (%) 47.0 ± 6.1 48.8 ± 3.7 51.4 ± 6.6 44.8 ± 4.1 29.6 ± 6.1 37.8 ± 3.9
Patient status Alive (%) 35 (48) 105 (51) 32 (54) 105 (57) 32 (54) 105 (57) Death (%) 38 (52) 101 (49) 27 (46) 80 (43) 27 (46) 80 (43) Relapsed (%) 17 (23) 64 (31) 17 (29) 64 (35) 17 (29) 64 (35) Age, median (%) P = 0.028 P = 0.007 P = 0.037 The results for the median follow-up are presented as the number of patients (range) for each condition; for the patient status as the number of patients (%); and for all the others as the estimates in percentage ± the standard error. Log-rank test was used to analyze the statistical significance for each variable. P < 0.05 was considered statistically significant (Bold values). NS represents not significant differences, and the estimates were not included in the table. CR; Complete remission. OS; Overall survival. DFS; Disease-free survival. CIR; Cumulative incidence of relapse.
